<DOC>
	<DOCNO>NCT00038064</DOCNO>
	<brief_summary>Chemotherapy often cause anemia patient cancer . Anemia low number red blood cell . The symptom anemia may include fatigue , dizziness , headache , chest pain , shortness breath . Erythropoietin hormone make kidney signal bone marrow produce red blood cell . Recombinant human erythropoietin produce laboratory effect hormone produce body . Use recombinant human erythropoietin allow body produce red blood cell , possibly eliminate decrease symptom need red blood cell transfusion . Recombinant human erythropoietin FDA approve treat anemia cancer patient receive chemotherapy . This clinical study investigate effectiveness darbepoetin alfa treatment anemia patient non-myeloid malignancy receive multicycle chemotherapy . Darbepoetin alfa recombinant erythropoietic protein stimulate production red blood cell . This medication approve treat cancer patient anemia , however approve FDA treat chronic renal failure patient anemia .</brief_summary>
	<brief_title>Anemia Patients With Non-Myeloid Malignancy</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Darbepoetin alfa</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Men woman legal age , diagnose nonmyeloid malignancy schedule receive least 12 additional week cyclic cytotoxic chemotherapy time first dose study drug Screening hemoglobin concentration less equal 11.0 g/dL ECOG performance status 0 2 ( inclusive ) History seizure disorder Primary hematologic disorder could cause anemia Unstable uncontrolled disease/condition relate affect cardiac function Clinical evidence chronic infection/inflammatory disease Positive test HIV infection Previously confirm neutralizing antibody rHuEPO Received rHuEPO darbepoetin alfa therapy within 4 week study day 1 2 RBC transfusion occurences</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>anemia cancer/chemotherapy</keyword>
	<keyword>non-myeloid malignancy</keyword>
	<keyword>Drug Therapy</keyword>
</DOC>